Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0ZGWEK
ADC Name
XB-010
Synonyms
XB 010; XB-010; XB010
   Click to Show/Hide
Organization
Exelixis, Inc.
Drug Status
Phase 1
Indication
In total 5 Indication(s)
Breast cancer
Phase 1
Clinical Trial
Head and neck cancer
Phase 1
Clinical Trial
Lung cancer
Phase 1
Clinical Trial
Oesophageal cancer
Phase 1
Clinical Trial
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
2
Antibody Name
Undisclosed
Antigen Name
Trophoblast glycoprotein (TPBG)
  Antigen Info 
Payload Name
Monomethyl auristatin E
  Payload Info 
Therapeutic Target
Microtubule (MT)
  Target Info 
Conjugate Type
Undisclosed